Lipocine Inc.

LPCN ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
SCHEDULE 13G May 15, 2026
SCHEDULE 13G/A May 15, 2026
8-K May 7, 2026 8-K
8-K May 7, 2026 8-K
10-Q May 7, 2026 10-Q
DEFA14A Apr 21, 2026 DEFA14A
DEF 14A Apr 21, 2026 DEF 14A
8-K Apr 21, 2026 8-K
4 Apr 7, 2026 4
4 Apr 6, 2026 4
4 Apr 6, 2026 4
4 Apr 2, 2026 4
8-K Apr 2, 2026 8-K
8-K Apr 2, 2026 8-K
8-K Mar 10, 2026 8-K
10-K Mar 10, 2026 10-K
8-K Mar 4, 2026 8-K
424B5 Feb 26, 2026 424B5
8-K Feb 18, 2026 8-K
8-K Feb 18, 2026 8-K
SCHEDULE 13G/A Feb 17, 2026
8-K Jan 20, 2026 8-K
8-K Jan 12, 2026 8-K
8-K Jan 12, 2026 8-K
4 Jan 5, 2026 4
← Newer Page 2 of 33 · 820 filings Older →